Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Role of hypertension on new onset congestive heart failure in patients receiving trastuzumab therapy for breast cancer.

Russo G, Cioffi G, Gori S, Tuccia F, Boccardi L, Khoury G, Lestuzzi C, Maurea N, Oliva S, Faggiano P, Tarantini L; ICARO (Italian CARdio-Oncological) Network.

J Cardiovasc Med (Hagerstown). 2014 Feb;15(2):141-6. doi: 10.2459/JCM.0b013e328365afb5.

PMID:
24534802
2.

Adjuvant trastuzumab cardiotoxicity in patients over 60 years of age with early breast cancer: a multicenter cohort analysis.

Tarantini L, Gori S, Faggiano P, Pulignano G, Simoncini E, Tuccia F, Ceccherini R, Bovelli D, Lestuzzi C, Cioffi G; ICARO (Italian CARdio-Oncologic) Network.

Ann Oncol. 2012 Dec;23(12):3058-63. doi: 10.1093/annonc/mds127. Epub 2012 Jun 13.

PMID:
22700991
3.

Trastuzumab adjuvant chemotherapy and cardiotoxicity in real-world women with breast cancer.

Tarantini L, Cioffi G, Gori S, Tuccia F, Boccardi L, Bovelli D, Lestuzzi C, Maurea N, Oliva S, Russo G, Faggiano P; Italian Cardio-Oncologic Network.

J Card Fail. 2012 Feb;18(2):113-9. doi: 10.1016/j.cardfail.2011.10.015. Epub 2011 Dec 3.

PMID:
22300778
4.

An induction dose of epoetin alpha of 40 000 IU daily for three consecutive days increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy.

Mustacchi G, Ceccherini R, Dellach C, Foladore S, Milani S, Leita M, Sisto M.

Ann Oncol. 2006 Nov;17(11):1705-8. Epub 2006 Sep 15.

PMID:
16980603
5.

Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial.

Mustacchi G, Ceccherini R, Milani S, Pluchinotta A, De Matteis A, Maiorino L, Farris A, Scanni A, Sasso F; Italian Cooperative Group GRETA.

Ann Oncol. 2003 Mar;14(3):414-20.

PMID:
12598347
6.

A phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer.

Mustacchi G, Muggia M, Milani S, Ceccherini R, Leita ML, Dellach C.

Ann Oncol. 2002 Nov;13(11):1730-6.

PMID:
12419744
7.

Results of adjuvant treatment in breast cancer women aged more than 70: Italian cooperative group experience.

Mustacchi G, Ceccherini R, Pluchinotta A, De Matteis A, Maiorino L, Farris A, Scanni A, De Placido S.

Tumori. 2002 Jan-Feb;88(1 Suppl 1):S83-5. No abstract available.

PMID:
11989936
8.
9.

[Effectiveness of sequential administration of G-CSF and GM-CSF after antineoplastic chemotherapy in patients with advanced tumors: results of a randomized trial].

Mustacchi G, Ceccherini R, Milani S, Sandri P, Leita ML, Carbonara T.

Tumori. 1997 Sep-Oct;83(5 Suppl):S13-6. Italian.

PMID:
9446253
10.

The combination of metoclopramide, methylprednisolone and ondansetron against antiblastic-delayed emesis: a randomised phase II study.

Mustacchi G, Ceccherini R, Leita ML, Sandri P, Milani S, Carbonara T.

Anticancer Res. 1997 Mar-Apr;17(2B):1345-8.

PMID:
9137496
11.

Role of vaginal surgery in the 1st stage endometrial cancer. Experience of the Florence School.

Scarselli G, Savino L, Ceccherini R, Barciulli F, Massi GB.

Eur J Gynaecol Oncol. 1992;13(1 Suppl):15-9.

PMID:
1511709
12.

[Suicide in Italy 1955-1980: description and epidemiological analysis].

Ceccherini R.

Ann Ig. 1989 Jan-Apr;1(1-2):313-50. Italian.

PMID:
2483076
13.

[Yersinia enterocolitica: biotypes and serotypes isolated from horticultural products].

Cavazzini G, Ceccherini R, Bolognesi L, Brandi A, Rausa G.

Boll Ist Sieroter Milan. 1983 Sep 30;62(4):317-22. Italian.

PMID:
6661289
14.

[Proposal for a dichotomic ramification scheme for the identification of non-fermentative Gram-negative bacteria].

Cavazzini G, Cenci P, Brandi A, Ceccherini R.

Nuovi Ann Ig Microbiol. 1982 Mar-Jun;33(2-3):391-417. Italian. No abstract available.

PMID:
7187037
15.

[First isolation of Yersinia enterocolitica in several horticultural products intended usually to be consumed fresh].

Cavazzini G, Ceccherini R, Prati L, Rausa G.

Boll Ist Sieroter Milan. 1982;61(5):428-31. Italian.

PMID:
6765383

Supplemental Content

Loading ...
Support Center